176 related articles for article (PubMed ID: 25546164)
41. Pharmacokinetics of a fixed-dose glimepiride/sustained-release metformin combination.
Kim KP; Lim KS; Kim BH; Shin HS; Cho JY; Shin SG; Jang IJ; Yu KS
Int J Clin Pharmacol Ther; 2012 Feb; 50(2):142-9. PubMed ID: 22257580
[TBL] [Abstract][Full Text] [Related]
42. Oral antidiabetic drugs: effect of food on absorption of pioglitazone and metformin from a fixed-dose combination tablet.
Karim A; Slater M; Bradford D; Schwartz L; Laurent A
J Clin Pharmacol; 2007 Jan; 47(1):48-55. PubMed ID: 17192501
[TBL] [Abstract][Full Text] [Related]
43. Bioequivalence of a fixed-dose repaglinide/metformin combination tablet and equivalent doses of repaglinide and metformin tablets
.
Cho HY; Ngo L; Kim SK; Choi Y; Lee YB
Int J Clin Pharmacol Ther; 2018 Jun; 56(6):292-300. PubMed ID: 29648532
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects.
Rhee SJ; Lee S; Yoon SH; Cho JY; Jang IJ; Yu KS
Drug Des Devel Ther; 2016; 10():1411-8. PubMed ID: 27110098
[TBL] [Abstract][Full Text] [Related]
45. Bioequivalence and food effect assessment for vildagliptin/metformin fixed-dose combination tablets relative to free combination of vildagliptin and metformin in Japanese healthy subjects.
Mita S; Chitnis SD; Kulmatycki K; Salunke A; He YL; Zhou W; Suzuki H
Int J Clin Pharmacol Ther; 2016 Apr; 54(4):305-14. PubMed ID: 26932305
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets.
Ghim JL; Phuong NTT; Kim MJ; Kim EJ; Song GS; Ahn S; Shin JG; Kim EY
Drug Des Devel Ther; 2019; 13():1623-1632. PubMed ID: 31190741
[No Abstract] [Full Text] [Related]
47. Bioequivalence of fixed-dose combinations of dapagliflozin and metformin with single-component tablets in healthy subjects and the effect of food on bioavailability.
de Bruin TW; Reele S; Hamer-Maansson JE; Parikh S; Tang W
Clin Pharmacol Drug Dev; 2016 Mar; 5(2):118-30. PubMed ID: 27138025
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg
.
Yoon S; Rhee SJ; Park SI; Yoon SH; Cho JY; Jang IJ; Lee S; Yu KS
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):533-539. PubMed ID: 28406090
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics of rosuvastatin/olmesartan fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.
Son H; Roh H; Lee D; Chang H; Kim J; Yun C; Park K
Clin Ther; 2013 Jul; 35(7):915-22. PubMed ID: 23810276
[TBL] [Abstract][Full Text] [Related]
50. Single-dose, randomized crossover comparisons of different-strength imatinib mesylate formulations in healthy Korean male subjects.
Kim KA; Park SJ; Kim C; Park JY
Clin Ther; 2013 Oct; 35(10):1595-602. PubMed ID: 24060561
[TBL] [Abstract][Full Text] [Related]
51. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers.
Parrillo-Campiglia S; Ercoli MC; Umpierrez O; Rodríguez P; Márquez S; Guarneri C; Estevez-Parrillo FT; Laurenz M; Estevez-Carrizo FE
Clin Ther; 2009 Oct; 31(10):2224-32. PubMed ID: 19922893
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study.
Cho SH; Lim HS; Ghim JL; Choe S; Kim UJ; Jung JA; Bae KS
Clin Ther; 2009 May; 31(5):1046-53. PubMed ID: 19539105
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetic and bioavailability studies of 5 mg mosapride tablets in healthy Korean volunteers.
Kim SH; Park YS; Kim JM; Park HJ; Lee MH; Park HK; Kim YJ; Cho SH; Shaw LM; Kang JS
Int J Clin Pharmacol Ther; 2012 Jul; 50(7):524-31. PubMed ID: 22541755
[TBL] [Abstract][Full Text] [Related]
54. Population pharmacokinetic modeling and noncompartmental analysis demonstrated bioequivalence between metformin component of metformin/vildagliptin fixed-dose combination products and metformin immediate-release tablet sourced from various countries.
Chitnis SD; Han Y; Yamaguchi M; Mita S; Zhao R; Sunkara G; Kulmatycki K
Clin Pharmacol Drug Dev; 2016 Jan; 5(1):40-51. PubMed ID: 27119577
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects.
Cho YS; Lee SH; Lim HS; Bae KS
J Korean Med Sci; 2018 Oct; 33(41):e258. PubMed ID: 30288156
[TBL] [Abstract][Full Text] [Related]
57. Single-dose, two-way crossover, bioequivalence study of Mycophenolate mofetil 500 mg tablet under fasting conditions in healthy male subjects.
Patel S; Chauhan V; Mandal J; Shah S; Patel K; Saptarshi D; Maheshwari K; Jha PK; Kale P; Patel K; Mathew P
Clin Ther; 2011 Mar; 33(3):378-90. PubMed ID: 21600390
[TBL] [Abstract][Full Text] [Related]
58. Bioequivalence of fixed dose combination of atorvastatin 10 mg and aspirin 150 mg capsules: a randomized, open-label, single-dose, two-way crossover study in healthy human subjects.
Tippabhotla SK; Betha MR; Gadiko C; Battula R; Nakkawar M; Cheerla R; Khan SM; Yergude S; Thota S; Vobalaboina V
Drug Res (Stuttg); 2013 May; 63(5):250-7. PubMed ID: 23526241
[TBL] [Abstract][Full Text] [Related]
59. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.
Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]